TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Canadian HIV Quit Smoking Trial: Tackling the Co-morbidities of Depression and Cardiovascular Disease in HIV+ Smokers
Brief Summary: The objectives of this trial are:

Primary objectives:

1. To determine among HIV+ individuals whether varenicline or NRT is more effective at helping individuals remain abstinent from smoking tobacco.
2. To determine among HIV+ individuals whether varenicline or NRT has the lowest side-effect profile.
3. To determine if the HIV tailored Quit Smoking Counselling Intervention, plus smoking cessation drug therapy, improves smoking cessation rates compared to smoking cessation drug therapy alone with usual care.

Secondary objective:

1. To determine whether the use of varenicline/NRT is safe in HIV+ patients who exhibit depressive symptoms.

Hypothesis:

That varenicline will result in higher quit smoking rates and that NRT will result in a lower side effect profile. Further, the HIV tailored quit smoking intervention will result in higher rates of smoking cessation over and above the pharmacological treatment alone. And finally, varenicline will be safe to use for HIV + individuals who exhibit depressive symptoms.


Options:
A: Intervention Type: DRUG; Name: CP-526,555 (varenicline); Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: sustained-release bupropion (Zyban(R)); Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Psychodynamic Model Training (R) = PDM(R); Assigned to Arm(s): N/A
C: Arm Label: Bupropion SR; Type: ACTIVE_COMPARATOR; Interventions: Drug: Bupropion SR | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo Oral Tablet | Intervention Type: DRUG; Name: Bupropion SR; Assigned to Arm(s): Bupropion SR | Intervention Type: DRUG; Name: Placebo Oral Tablet; Assigned to Arm(s): Placebo
D: Arm Label: NRT arm; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nicotine Replacement Therapy (NRT) | Arm Label: NRT and HIV Tailored Quit Smoking Counseling; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nicotine Replacement Therapy (NRT), Behavioral: HIV Tailored Quit Smoking Counseling | Arm Label: Varenicline (VR) Arm; Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline | Arm Label: Varenicline (VR) and HIV Tailored Quit Smoking Counseling; Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline, Behavioral: HIV Tailored Quit Smoking Counseling | Intervention Type: DRUG; Name: Nicotine Replacement Therapy (NRT); Assigned to Arm(s): NRT and HIV Tailored Quit Smoking Counseling, NRT arm | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Varenicline (VR) Arm, Varenicline (VR) and HIV Tailored Quit Smoking Counseling | Intervention Type: BEHAVIORAL; Name: HIV Tailored Quit Smoking Counseling; Assigned to Arm(s): NRT and HIV Tailored Quit Smoking Counseling, Varenicline (VR) and HIV Tailored Quit Smoking Counseling

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Functional Impact of GLP-1 for Heart Failure Treatment
Brief Summary: The primary objective is to test the hypothesis that, compared with placebo, therapy with Subcutaneous (SQ) GLP-1 agonist in the post-Acute Heart Failure Syndrome (AHFS) discharge period will be associated with greater clinical stability at six months as assessed by a composite clinical endpoint.


Options:
A: Arm Label: Dapagliflozin; Type: EXPERIMENTAL; Interventions: Drug: Dapagliflozin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Dapagliflozin; Assigned to Arm(s): Dapagliflozin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: BI 1356 5mg, once daily; Type: EXPERIMENTAL; Interventions: Drug: Placebo identical to Glimepiride 1mg or 2mg or 3mg or 4 mg, Drug: BI 1356 | Arm Label: Glimepiride; Type: ACTIVE_COMPARATOR; Interventions: Drug: Placebo identical to BI 1356 5mg, Drug: Glimepiride | Intervention Type: DRUG; Name: Placebo identical to BI 1356 5mg; Assigned to Arm(s): Glimepiride | Intervention Type: DRUG; Name: Placebo identical to Glimepiride 1mg or 2mg or 3mg or 4 mg; Assigned to Arm(s): BI 1356 5mg, once daily | Intervention Type: DRUG; Name: BI 1356; Assigned to Arm(s): BI 1356 5mg, once daily | Intervention Type: DRUG; Name: Glimepiride; Assigned to Arm(s): Glimepiride
C: Arm Label: Linagliptin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Linagliptin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Linagliptin; Assigned to Arm(s): Linagliptin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Liraglutide; Type: ACTIVE_COMPARATOR; Interventions: Drug: Liraglutide | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Liraglutide; Assigned to Arm(s): Liraglutide | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase 2 Study of the Efficacy of Voucher-Based Incentives to Treat Pregnant Smokers
Brief Summary: The major goal of this project is to examine the efficacy of a voucher-based incentive program for promoting smoking cessation (Study 1) and preventing relapse (Study 2) during pregnancy and postpartum. Identifying efficacious interventions to increase cessation rates and decrease relapse among those who are able to quit is important to improving U.S. public health.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Computerized brief intervention (5As); Type: EXPERIMENTAL; Interventions: Behavioral: Computer-delivered brief intervention (5As) | Arm Label: Contingency Management Alone; Type: EXPERIMENTAL; Interventions: Behavioral: Contingency Management | Arm Label: Combined Brief Intervention and CM; Type: EXPERIMENTAL; Interventions: Behavioral: Computer-delivered brief intervention (5As), Behavioral: Contingency Management | Intervention Type: BEHAVIORAL; Name: Computer-delivered brief intervention (5As); Assigned to Arm(s): Combined Brief Intervention and CM, Computerized brief intervention (5As) | Intervention Type: BEHAVIORAL; Name: Contingency Management; Assigned to Arm(s): Combined Brief Intervention and CM, Contingency Management Alone
B: Arm Label: Original contingent vouchers schedule; Type: EXPERIMENTAL; Interventions: Behavioral: Voucher-based incentives | Arm Label: Revised contingent vouchers schedule; Type: EXPERIMENTAL; Interventions: Behavioral: Voucher-based incentives | Arm Label: Non-contingent vouchers schedule; Type: SHAM_COMPARATOR; Interventions: Behavioral: Voucher-based incentives | Intervention Type: BEHAVIORAL; Name: Voucher-based incentives; Assigned to Arm(s): Non-contingent vouchers schedule, Original contingent vouchers schedule, Revised contingent vouchers schedule
C: Arm Label: Group commitment contracts; Type: EXPERIMENTAL; Interventions: Behavioral: Group commitment contract, Behavioral: Smoking cessation education and counseling | Arm Label: Education and counseling; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Smoking cessation education and counseling | Intervention Type: BEHAVIORAL; Name: Group commitment contract; Assigned to Arm(s): Group commitment contracts | Intervention Type: BEHAVIORAL; Name: Smoking cessation education and counseling; Assigned to Arm(s): Education and counseling, Group commitment contracts
D: Arm Label: Smoking-cessation treatment + substance treatment as usual; Type: EXPERIMENTAL; Interventions: Other: Smoking-cessation treatment | Arm Label: Substance-treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Smoking-cessation treatment; Assigned to Arm(s): Smoking-cessation treatment + substance treatment as usual

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase 2 Study of the Efficacy of Voucher-Based Incentives to Treat Pregnant Smokers
Brief Summary: The major goal of this project is to examine the efficacy of a voucher-based incentive program for promoting smoking cessation (Study 1) and preventing relapse (Study 2) during pregnancy and postpartum. Identifying efficacious interventions to increase cessation rates and decrease relapse among those who are able to quit is important to improving U.S. public health.


Options:
A: Arm Label: Incentives; Type: EXPERIMENTAL; Interventions: Behavioral: NH Medicaid Incentives Program | Arm Label: No Incentives; Type: EXPERIMENTAL; Interventions: Behavioral: NH Medicaid Incentives Program | Intervention Type: BEHAVIORAL; Name: NH Medicaid Incentives Program; Assigned to Arm(s): Incentives, No Incentives
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention | Arm Label: Enhanced Traditional Care control; Type: ACTIVE_COMPARATOR; Interventions: Other: Enhanced Traditional Care control | Intervention Type: BEHAVIORAL; Name: Intervention; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Enhanced Traditional Care control; Assigned to Arm(s): Enhanced Traditional Care control
C: Arm Label: Original contingent vouchers schedule; Type: EXPERIMENTAL; Interventions: Behavioral: Voucher-based incentives | Arm Label: Revised contingent vouchers schedule; Type: EXPERIMENTAL; Interventions: Behavioral: Voucher-based incentives | Arm Label: Non-contingent vouchers schedule; Type: SHAM_COMPARATOR; Interventions: Behavioral: Voucher-based incentives | Intervention Type: BEHAVIORAL; Name: Voucher-based incentives; Assigned to Arm(s): Non-contingent vouchers schedule, Original contingent vouchers schedule, Revised contingent vouchers schedule
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Computerized brief intervention (5As); Type: EXPERIMENTAL; Interventions: Behavioral: Computer-delivered brief intervention (5As) | Arm Label: Contingency Management Alone; Type: EXPERIMENTAL; Interventions: Behavioral: Contingency Management | Arm Label: Combined Brief Intervention and CM; Type: EXPERIMENTAL; Interventions: Behavioral: Computer-delivered brief intervention (5As), Behavioral: Contingency Management | Intervention Type: BEHAVIORAL; Name: Computer-delivered brief intervention (5As); Assigned to Arm(s): Combined Brief Intervention and CM, Computerized brief intervention (5As) | Intervention Type: BEHAVIORAL; Name: Contingency Management; Assigned to Arm(s): Combined Brief Intervention and CM, Contingency Management Alone

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase 2 Study of the Efficacy of Voucher-Based Incentives to Treat Pregnant Smokers
Brief Summary: The major goal of this project is to examine the efficacy of a voucher-based incentive program for promoting smoking cessation (Study 1) and preventing relapse (Study 2) during pregnancy and postpartum. Identifying efficacious interventions to increase cessation rates and decrease relapse among those who are able to quit is important to improving U.S. public health.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Computerized brief intervention (5As); Type: EXPERIMENTAL; Interventions: Behavioral: Computer-delivered brief intervention (5As) | Arm Label: Contingency Management Alone; Type: EXPERIMENTAL; Interventions: Behavioral: Contingency Management | Arm Label: Combined Brief Intervention and CM; Type: EXPERIMENTAL; Interventions: Behavioral: Computer-delivered brief intervention (5As), Behavioral: Contingency Management | Intervention Type: BEHAVIORAL; Name: Computer-delivered brief intervention (5As); Assigned to Arm(s): Combined Brief Intervention and CM, Computerized brief intervention (5As) | Intervention Type: BEHAVIORAL; Name: Contingency Management; Assigned to Arm(s): Combined Brief Intervention and CM, Contingency Management Alone
B: Arm Label: Original contingent vouchers schedule; Type: EXPERIMENTAL; Interventions: Behavioral: Voucher-based incentives | Arm Label: Revised contingent vouchers schedule; Type: EXPERIMENTAL; Interventions: Behavioral: Voucher-based incentives | Arm Label: Non-contingent vouchers schedule; Type: SHAM_COMPARATOR; Interventions: Behavioral: Voucher-based incentives | Intervention Type: BEHAVIORAL; Name: Voucher-based incentives; Assigned to Arm(s): Non-contingent vouchers schedule, Original contingent vouchers schedule, Revised contingent vouchers schedule
C: Arm Label: 1 - CBT Counseling; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Motivational interviewing for smoking cessation, Behavioral: Cognitive behaviors therapy | Arm Label: 2 - Counseling + NRT; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational interviewing for smoking cessation, Drug: CBT + NRT | Intervention Type: BEHAVIORAL; Name: Motivational interviewing for smoking cessation; Assigned to Arm(s): 1 - CBT Counseling, 2 - Counseling + NRT | Intervention Type: BEHAVIORAL; Name: Cognitive behaviors therapy; Assigned to Arm(s): 1 - CBT Counseling | Intervention Type: DRUG; Name: CBT + NRT; Assigned to Arm(s): 2 - Counseling + NRT
D: Arm Label: High intensity intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Higher intensity intervention | Arm Label: Low intensity intervention; Type: OTHER; Interventions: Behavioral: Low intensity intervention | Intervention Type: BEHAVIORAL; Name: Low intensity intervention; Assigned to Arm(s): Low intensity intervention | Intervention Type: BEHAVIORAL; Name: Higher intensity intervention; Assigned to Arm(s): High intensity intervention

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: E-Cuidate: Effectiveness of a Telerehabilitation System in Women Breast Cancer Survivors
Brief Summary: Background: Cancer is increasingly viewed as a chronic disease and therefore there is a growing need for long-term treatments. Breast cancer survivors suffer physical impairment after oncology treatment. This impairment reduces quality of life (QoL) and increases the prevalence of conditions associated to unhealthy life-style.

Objective: The overall objective of e-Cuidate telerehabilitation will be to evaluate short and long-term effects telehealth program.

Methods: Seventy-two breast cancer survivors (age range: 18-65 years) will be recruited through oncology and breast units at the Virgen de las Nieves Hospital and San Cecilio Hospital and associations of breast cancer patients in Granada. Patients will be randomized to receive the online rehabilitation group (n=36) or usual care (control) group (n=36). Telerehabilitation group will receive an eight-week online intervention and control group receive recommendations about usual care.

Discussion: The investigators study attempts to increase the level of fitness and reduce musculoskeletal disorders in breast cancer patients through a strategy for care based on telerehabilitation to promote therapeutic exercise.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: CBT and relaxation | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Physical activity | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Behavioral: CBT and physical activity | Arm Label: 4; Type: NO_INTERVENTION; Interventions: Other: Control group | Intervention Type: BEHAVIORAL; Name: CBT and relaxation; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Physical activity; Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: CBT and physical activity; Assigned to Arm(s): 3 | Intervention Type: OTHER; Name: Control group; Assigned to Arm(s): 4
B: Arm Label: Telerehabilitation group; Type: EXPERIMENTAL; Interventions: Behavioral: Telerehabilitation group | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Telerehabilitation group; Assigned to Arm(s): Telerehabilitation group
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Yoga | Arm Label: 2; Type: OTHER; Interventions: Other: Delayed yoga classes | Intervention Type: BEHAVIORAL; Name: Yoga; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Delayed yoga classes; Assigned to Arm(s): 2
D: Intervention Type: BEHAVIORAL; Name: exercise intervention; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: complementary or alternative medicine procedure; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: fatigue assessment and management; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: physical therapy; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: E-Cuidate: Effectiveness of a Telerehabilitation System in Women Breast Cancer Survivors
Brief Summary: Background: Cancer is increasingly viewed as a chronic disease and therefore there is a growing need for long-term treatments. Breast cancer survivors suffer physical impairment after oncology treatment. This impairment reduces quality of life (QoL) and increases the prevalence of conditions associated to unhealthy life-style.

Objective: The overall objective of e-Cuidate telerehabilitation will be to evaluate short and long-term effects telehealth program.

Methods: Seventy-two breast cancer survivors (age range: 18-65 years) will be recruited through oncology and breast units at the Virgen de las Nieves Hospital and San Cecilio Hospital and associations of breast cancer patients in Granada. Patients will be randomized to receive the online rehabilitation group (n=36) or usual care (control) group (n=36). Telerehabilitation group will receive an eight-week online intervention and control group receive recommendations about usual care.

Discussion: The investigators study attempts to increase the level of fitness and reduce musculoskeletal disorders in breast cancer patients through a strategy for care based on telerehabilitation to promote therapeutic exercise.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise
B: Arm Label: Acupuncture & educ; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Acupuncture and patient education | Arm Label: 2. Standard care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Acupuncture and patient education; Assigned to Arm(s): Acupuncture & educ
C: Intervention Type: PROCEDURE; Name: Memory Training; Assigned to Arm(s): N/A
D: Arm Label: Telerehabilitation group; Type: EXPERIMENTAL; Interventions: Behavioral: Telerehabilitation group | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Telerehabilitation group; Assigned to Arm(s): Telerehabilitation group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Accuracy of SPD Persona LH Assay When Compared to Ultrasound Observed Ovulation and Other Indices of Ovulation
Brief Summary: This study will examine the performance of the Persona assays in identifying the time when risk of pregnancy is highest by comparing results to ultrasound observed ovulation and other indices of ovulation.


Options:
A: Arm Label: sample collection; Type: OTHER; Interventions: Other: Ovulation predictions products | Intervention Type: OTHER; Name: Ovulation predictions products; Assigned to Arm(s): sample collection
B: Arm Label: Electronic hormonal fertility monitoring; Type: EXPERIMENTAL; Interventions: Behavioral: Electronic hormonal fertility monitoring | Arm Label: Cervical mucus monitoring; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-monitoring | Intervention Type: BEHAVIORAL; Name: Electronic hormonal fertility monitoring; Assigned to Arm(s): Electronic hormonal fertility monitoring | Intervention Type: BEHAVIORAL; Name: Self-monitoring; Assigned to Arm(s): Cervical mucus monitoring
C: N/A
D: Arm Label: COTS; Type: ACTIVE_COMPARATOR; Interventions: Device: Clearblue Connected Ovulation Test System | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Clearblue Connected Ovulation Test System; Assigned to Arm(s): COTS

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Trial of Vaginal Surgery for Uterovaginal Prolapse: Vaginal Hysterectomy With Native Tissue Vault Suspension vs. Mesh Hysteropexy Suspension
Brief Summary: The primary purpose of this randomized clinical trial is to compare the effectiveness and safety of two transvaginal apical suspension strategies for uterovaginal prolapse: a mesh augmented hysteropexy versus vaginal hysterectomy and uterosacral ligament suspension (USLS). The primary aim is to determine whether treatment success in women who undergo the above strategies differ at time points through 3 years.

A supplemental study investigates anterior vaginal wall movement resulting from descent or rotation of the vaginal apex and/or anterior vaginal elongation, in women in both of the study arms of SUPeR.


Options:
A: Arm Label: Interrupted suture; Type: ACTIVE_COMPARATOR; Interventions: Device: Device is the type of suture used: Quill suture vs. Interrupted suture | Arm Label: Quill suture; Type: ACTIVE_COMPARATOR; Interventions: Device: Device is the type of suture used: Quill suture vs. Interrupted suture | Intervention Type: DEVICE; Name: Device is the type of suture used: Quill suture vs. Interrupted suture; Assigned to Arm(s): Interrupted suture, Quill suture
B: Arm Label: SSLF and PMT; Type: EXPERIMENTAL; Interventions: Procedure: SSLF, Behavioral: PMT | Arm Label: ULS and PMT; Type: EXPERIMENTAL; Interventions: Procedure: ULS, Behavioral: PMT | Arm Label: SSLF without PMT; Type: EXPERIMENTAL; Interventions: Procedure: SSLF | Arm Label: ULS without PMT; Type: EXPERIMENTAL; Interventions: Procedure: ULS | Intervention Type: PROCEDURE; Name: SSLF; Assigned to Arm(s): SSLF and PMT, SSLF without PMT | Intervention Type: PROCEDURE; Name: ULS; Assigned to Arm(s): ULS and PMT, ULS without PMT | Intervention Type: BEHAVIORAL; Name: PMT; Assigned to Arm(s): SSLF and PMT, ULS and PMT
C: Intervention Type: PROCEDURE; Name: sacral colpopexy; Assigned to Arm(s): N/A
D: Arm Label: Hysteropexy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Uphold® LITE | Arm Label: Hysterectomy and USLS; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Uterosacral ligament suspension | Intervention Type: PROCEDURE; Name: Uterosacral ligament suspension; Assigned to Arm(s): Hysterectomy and USLS | Intervention Type: PROCEDURE; Name: Uphold® LITE; Assigned to Arm(s): Hysteropexy

Answer: D